ArticleFrontiers in oncology2023

Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma.

Cristina Di Giorgio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.